Icotinib Versus First-line Chemotherapy Plus Maintenance Treatment in EGFR Positive Lung Adenocarcinoma Patients
Clinical trial NCT01719536 · COMPLETED
Trial details
- NCT number
- NCT01719536
- Sponsor
- Betta Pharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-01
- Primary completion
- 2016-09-01
- Enrollment
- 296
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.